T2 Biosystems Garners $15,000,000 Series C Funding

  • Feed Type
  • Date
  • Company Name
    T2 Biosystems
  • Mailing Address
    286 Cardinal Medeiros Avenue Cambridge, MA 02141
  • Company Description
    T2 Biosystems is a newly formed diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at MIT and Massachusetts General Hospital. Using this technology, we are developing a range of diagnostic products to impact a variety of health care settings; from centralized testing laboratories to point of care.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds from the financing will be usedto accelerate the development and commercialization of T2 Biosystems’ next generation diagnosticplatform for use in the decentralized setting.
  • M&A Terms
  • Venture Investor
    Physic Ventures
  • Venture Investor
    Arcus Ventures
  • Venture Investor
    Polaris Venture Partners
  • Venture Investor
    Flybridge Capital Partners
  • Venture Investor
    WS Investment
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Partners HealthCare System

Trending on Xconomy